Open AccessReasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
Author(s) -
Ludovic Plaisance,
Céline Chapelle,
Silvy Laporte,
Benjamin Planquette,
Laurent Bertoletti,
Nicolas Falvo,
F. Couturaud,
L. Falchero,
I. Mahé,
H. L. Helfer,
Sadji Dennaoui,
Guy Meyer,
Isabelle Mahé
Publication year - 2021
Publication title -
journal of cancer science and clinical therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2637-5079
DOI - 10.26502/jcsct.5079122
Subject(s) - medicine , vitamin k antagonist , anticoagulant , retrospective cohort study , thrombosis , anticoagulant therapy , cancer , surgery , warfarin , atrial fibrillation
Few data are available about anticoagulation management beyond 6 months in patients with cancer associated thrombosis (CAT). Our objective was to describe anticoagulant treatment modalities up to 12 months.